SPDR S&P Biotech ETF $129.44

down -0.93


24/4/2014 04:15 PM  |  NYSEARCA : XBI
Get Trend Analysis Icon Get XBI Trend Analysis - it has outperformed the S&P 500 by 3%

Partner Headlines

  1. ETF Outlook For Wednesday, April 16, 2014 (SMH, IAT, XBI, EWS, INTC, USB)

    Benzinga
  2. Friday's Downside: The Fun Didn't Last Long

    Benzinga
  3. Biotechs Struggling To Find A Bottom

    Benzinga
  4. A Tale of Two Headlines

    Benzinga
  5. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  6. Biotech ETFs Come Back Down To Earth

    Benzinga
  7. Are Earnings Important? These Days, Revenues Count for More!

    GuruFocus
  8. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  9. ETF Outlook For Wednesday, March 12, 2014 (XBI, RSX, WEAT, JJC, COPX)

    Benzinga
  10. Another Long-Term Sell Signal Worth Noting

    Benzinga
  11. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  12. ETF Outlook for Friday, January 10, 2014 (IYT, RSX, EWZ, XBI)

    Benzinga
  13. Trade of the Day: Long CLDX

    Benzinga
  14. Trade Idea of the Day: Short Vertex

    Benzinga
  15. Why Clovis Oncology Was The Short Trade Of The Day

    Benzinga
  16. ETF Winners on Possible Debt Deal (ITB, XLF, ITA, SOCL, XBI)

    Benzinga
  17. ETF Outlook for October 10, 2013 (EWU, EWZ, XBI)

    Benzinga
  18. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  19. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  20. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  21. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  22. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  23. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  24. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  25. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  26. Acadia Pharma Rockets Higher on Study Results

    Benzinga
  27. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  28. After Surging, Homebuilder ETFs Look Pricey

    Benzinga
  29. A Look Ahead: This Week's ETFs to Watch

    Benzinga
  30. Best & Worst ETFs & Mutual Funds: Health Care Sector

    Benzinga
  31. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  32. S&P Likes a Trio of Biotech ETFs

    Benzinga
  33. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  34. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  35. When Cheaper Is Better With ETFs

    Benzinga
  36. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  37. ETFs to Watch July 27, 2012 (EWG, TBT, VDE)

    Benzinga
  38. Biotechs With Upcoming PDUFA Dates

    Benzinga
  39. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  40. ETFs to Watch July 12, 2012 (HYD, SOXS, XLE)

    Benzinga
  41. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  42. These Are Four of the Hottest Biotechs in the Market Right Now

    Benzinga
  43. ETFs to Watch June 28, 2012 (CURE, XBI, FCG)

    Benzinga
  44. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  45. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  46. Disney, Raytheon and Other Avenger Picks for a Heroic Portfolio

    Benzinga
  47. In a Shaky Market, Biotech Stocks Are Still Working

    SchaeffersResearch
  48. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  49. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  50. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
Trading Center